Healthcare - Genomics & Precision Medicine
Companies in gene therapy, genetic testing, and personalized medicine platforms
Gene Therapy & Gene Editing60
RNA Therapeutics10
Genetic Testing & Diagnostics23
Precision Medicine Platforms49
| Ticker | Company | Sub-Theme | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|---|
 AZN | AstraZeneca PLC | Precision Medicine Platforms | $300.7b | $202.01 | -1.0% | 7.8K |
 TMO | Thermo Fisher Scientific, Inc. | Precision Medicine Platforms | $178.3b | $495.53 | -0.1% | 11 |
 DHR | Danaher Corporation | Precision Medicine Platforms | $130.1b | $189.49 | -0.1% | 102 |
 VRTX | Vertex Pharmaceuticals Inc | Gene Therapy & Gene Editing | $112.6b | $436.29 | +0.0% | 168 |
 REGN | Regeneron Pharmaceuticals Inc | Gene Therapy & Gene Editing | $79.2b | $748.96 | +0.0% | 44 |
 ALNY | Alnylam Pharmaceuticals, Inc. | RNA Therapeutics | $41.9b | $322.21 | +0.0% | 131 |
 INSM | Insmed, Inc. | Gene Therapy & Gene Editing | $33.0b | $154.87 | +0.0% | 1.6M |
 WAT | Waters Corp | Precision Medicine Platforms | $28.8b | $319.80 | -0.1% | 2 |
 NTRA | Natera, Inc. Common Stock | Genetic Testing & Diagnostics | $26.5b | $193.11 | +0.0% | 64 |
 LH | Labcorp Holdings Inc. | Genetic Testing & Diagnostics | $21.7b | $260.93 | 0.0% | N/A |
 ILMN | Illumina Inc | Genetic Testing & Diagnostics | $18.5b | $120.92 | -0.0% | 322 |
 BBIO | BridgeBio Pharma, Inc. Common Stock | Precision Medicine Platforms | $13.4b | $74.61 | +0.0% | 20 |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | RNA Therapeutics | $12.0b | $75.19 | +0.0% | 1.3M |
 GH | Guardant Health, Inc. Common Stock | Precision Medicine Platforms | $11.3b | $78.61 | +0.0% | 250 |
 BMRN | BioMarin Pharmaceuticals Inc | Gene Therapy & Gene Editing | $10.5b | $54.52 | -0.0% | 235 |
 RVTY | Revvity, Inc. | Precision Medicine Platforms | $9.5b | $89.79 | 0.0% | 544.4K |
 TECH | Bio-Techne Corp. | Precision Medicine Platforms | $8.1b | $55.56 | +0.0% | 1 |
 QGEN | QIAGEN N.V. | Genetic Testing & Diagnostics | $8.1b | $40.51 | -0.9% | 1.1K |
 ARWR | Arrowhead Research Corporation | RNA Therapeutics | $8.1b | $65.16 | +0.0% | 269 |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | Precision Medicine Platforms | $7.7b | $315.68 | -0.1% | 1 |
 NUVL | Nuvalent, Inc. Class A Common Stock | Precision Medicine Platforms | $7.6b | $102.84 | +0.1% | 503 |
 TEM | Tempus AI, Inc. Class A Common Stock | Precision Medicine Platforms | $7.6b | $42.95 | +0.0% | 129.8K |
 KRYS | Krystal Biotech, Inc. Common Stock | Gene Therapy & Gene Editing | $7.2b | $259.27 | +0.1% | 47 |
 KYMR | Kymera Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $6.5b | $85.08 | +0.0% | 371 |
 CAI | Caris Life Sciences, Inc. Common Stock | Precision Medicine Platforms | $4.8b | $18.05 | 0.0% | 705 |
 LNTH | Lantheus Holdings, Inc | Precision Medicine Platforms | $4.8b | $80.56 | -0.0% | 6 |
 FOLD | Amicus Therapeutics, Inc | Gene Therapy & Gene Editing | $4.5b | $14.46 | 0.0% | 3 |
 CRSP | CRISPR Therapeutics AG | Gene Therapy & Gene Editing | $4.3b | $51.24 | +0.0% | 1.2K |
 BLLN | BillionToOne, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $3.2b | $80.78 | -0.4% | N/A |
 DYN | Dyne Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $2.8b | $18.67 | -0.1% | 1.0M |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | Precision Medicine Platforms | $2.8b | $30.49 | -0.0% | 439.0K |
 TWST | Twist Bioscience Corporation Common Stock | Precision Medicine Platforms | $2.7b | $47.95 | +0.1% | 532 |
 TXG | 10x Genomics, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $2.5b | $23.28 | +0.0% | 655 |
 VCYT | Veracyte, Inc. | Genetic Testing & Diagnostics | $2.4b | $31.05 | -0.1% | 3.2K |
 BEAM | Beam Therapeutics Inc. Common Stock | Gene Therapy & Gene Editing | $2.2b | $27.45 | +0.1% | 787 |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | Gene Therapy & Gene Editing | $2.2b | $21.20 | +0.1% | 335 |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | Precision Medicine Platforms | $2.0b | $12.79 | +0.0% | 65 |
 WGS | GeneDx Holdings Corp. Class A Common Stock | Genetic Testing & DiagnosticsPrecision Medicine Platforms | $1.7b | $59.56 | -0.1% | 69 |
 VCEL | Vericel Corporation | Gene Therapy & Gene Editing | $1.6b | $33.71 | +0.0% | 15 |
 MAZE | Maze Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $1.4b | $26.69 | 0.0% | 104 |
 NTLA | Intellia Therapeutics, Inc | Gene Therapy & Gene Editing | $1.4b | $13.50 | +0.1% | 1.8K |
 WVE | Wave Life Sciences Ltd. Ordinary Shares | RNA Therapeutics | $1.2b | $7.19 | +0.1% | 525 |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | Gene Therapy & Gene Editing | $1.2b | $4.49 | 0.0% | 1.3M |
 PGEN | Precigen, Inc. Common Stock | Gene Therapy & Gene Editing | $1.2b | $4.15 | -0.2% | 709 |
 PCRX | Pacira BioSciences, Inc. Common Stock | Gene Therapy & Gene Editing | $0.9b | $23.77 | -0.1% | 642 |
 NEO | NeoGenomics, Inc. | Genetic Testing & Diagnostics | $0.9b | $7.68 | -0.1% | 2.5K |
 AZTA | Azenta, Inc. | Genetic Testing & Diagnostics | $0.9b | $22.22 | +0.0% | 811 |
 QURE | uniQure N.V. | Gene Therapy & Gene Editing | $0.9b | $15.39 | +0.1% | 137 |
 BLFS | BioLife Solutions Inc. | Gene Therapy & Gene Editing | $0.9b | $19.73 | -0.0% | N/A |
 CDNA | CareDx, Inc. | Genetic Testing & DiagnosticsPrecision Medicine Platforms | $0.8b | $16.04 | -0.1% | 731 |